Bank Pictet & Cie (Asia)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.3M Buy
1,439
+17
+1% +$13.6K 0.08% 40
2024
Q1
$1.11M Sell
1,422
-1,867
-57% -$1.33M 0.09% 39
2023
Q4
$1.92M Hold
3,289
0.49% 33
2023
Q3
$1.77M Sell
3,289
-82
-2% -$42.3K 0.52% 30
2023
Q2
$1.58M Sell
3,371
-1,085
-24% -$455K 0.47% 35
2023
Q1
$1.53M Buy
4,456
+277
+7% +$93.4K 0.52% 33
2022
Q4
$1.53M Buy
4,179
+241
+6% +$85.4K 0.55% 32
2022
Q3
$1.27M Sell
3,938
-155
-4% -$49.1K 0.5% 32
2022
Q2
$1.33M Sell
4,093
-2,218
-35% -$666K 0.45% 35
2022
Q1
$1.81M Hold
6,311
0.49% 33
2021
Q4
$1.74M Buy
6,311
+291
+5% +$73.8K 0.41% 42
2021
Q3
$1.39M Sell
6,020
-1,476
-20% -$364K 0.39% 52
2021
Q2
$1.72M Buy
+7,496
New +$1.51M 0.48% 34

Other funds holding LLY

Bank Pictet & Cie (Asia)'s LLY Position: Q2 2024 in Review

Bank Pictet & Cie (Asia) increased its Eli Lilly (LLY) stake by 1.2% in Q2 2024, buying an estimated $13.6K and bringing the position to 1,439 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #40.

Bank Pictet & Cie (Asia) first reported a position in LLY in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.92M in Q4 2023. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Bank Pictet & Cie (Asia) held 1,439 shares of Eli Lilly worth $1.3M as of Q2 2024.
  • Bank Pictet & Cie (Asia) bought 17 Eli Lilly shares in Q2 2024, an estimated $13.6K.
  • Eli Lilly made up 0.08% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #40 holding.
  • Bank Pictet & Cie (Asia) first reported a position in Eli Lilly in Q2 2021 and has held it in 13 quarters since.
  • Bank Pictet & Cie (Asia)'s Eli Lilly position peaked at $1.92M in Q4 2023.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.